多参数成像技术(MULTIPLEX)对弥漫性胶质瘤分级及分子分型的评估价值
研究纳入72例弥漫性胶质瘤患者,评估单次扫描三维多参数MRI技术MULTIPLEX(提供T1、T2*、质子密度及定量磁化率图)在胶质瘤分级和分子亚型评估中的价值,发现低级别、IDH突变、MGMT甲基化及EGFR非扩增胶质瘤的坏死或强化区平均T2*值显著更高,T1偏度及QSM标准差等参数在分级和分子亚型间存在显著差异。
要点
- 低级别、IDH突变、MGMT甲基化及EGFR非扩增胶质瘤坏死或强化区平均T2*值显著高于对应组。
- 低级别肿瘤坏死区T1偏度及QSM标准差显著低于4级胶质瘤。
- 1p/19q共缺失与非共缺失胶质瘤间水肿区QSM偏度及强化肿瘤PD标准差存在显著差异。
核心结论
- MULTIPLEX可对T1、T2*、PD及QSM参数所捕获的胶质瘤相关区域进行综合定量评估,尤其T2*和QSM在弥漫性胶质瘤分级和分子亚型评估中展现出可观前景。
研究设计与样本
- 研究纳入72例弥漫性胶质瘤患者,均接受常规MRI和MULTIPLEX采集;对常规结构数据进行图像预处理和自动分割,将肿瘤区域自动分割为对比强化肿瘤、水肿区和坏死体积;从T1、T2*、PD及QSM定量图中提取每个感兴趣区的分布指标(均值、标准差、偏度、峰度),共获得48个代表肿瘤相关区域定量属性的参数;采用Mann-Whitney检验比较不同肿瘤级别和分子亚型间的各定量参数。
诊断标准与关键数值
- 低级别、IDH突变、MGMT甲基化及EGFR非扩增胶质瘤坏死或强化区平均T2*值显著高于4级、IDH野生型、MGMT非甲基化及EGFR扩展胶质瘤。
- 低级别肿瘤坏死区T1值偏度和QSM值标准差显著低于4级胶质瘤。
- 1p/19q共缺失与非共缺失胶质瘤间水肿区QSM值偏度和强化肿瘤PD值标准差存在显著差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the value of MULTIPLEX, a single-scan three-dimensional multiparametric magnetic resonance imaging (MRI) quantitative technique providing T1, T2∗, proton density (PD), and quantitative susceptibility mapping (QSM) maps, in grading gliomas and assessing molecular subtypes.
MATERIALS AND METHODS: We recruited 72 diffuse glioma patients who underwent conventional MRI and MULTIPLEX acquisition. Image preprocessing and automatic segmentation were applied to conventional structural data. The tumour region was automatically segmented into contrast-enhancing tumour, oedematous, and necrotic volumes. Distribution metrics (mean, standard deviation, skewness, and kurtosis) were extracted from quantitative maps (T1, T2∗, PD, and QSM) for each tumour region of interest (ROI) using histogram analysis. A total of 48 parameters representing the quantitative properties of tumour-related regions were obtained. The Mann-Whitney test was performed for each quantitative parameter between different tumour grades and molecular subtypes.
RESULTS: Low-grade, isocitrate dehydrogenase (IDH) mutant, oxygen6-methylguanine-DNA methyltransferase (MGMT) methylated, and epidermal growth factor receptor (EGFR) nonamplifying gliomas had significantly higher average T2∗ values in necrotic or enhanced areas than grade 4, IDH-wildtype, MGMT non-methylated, and EGFR extended gliomas. The skewness of T1 values and the standard deviation of QSM values in the necrotic area of low-grade tumours were significantly lower than those in grade 4 gliomas. There were significant differences in the skewness of oedema QSM values and the standard deviation of enhanced tumour PD between 1p/19q codeficient and non-co-deficient gliomas.
CONCLUSION: MULTIPLEX can be used for comprehensive quantitative assessment of glioma-related regions captured in T1, T2∗, PD, and QSM parameters, especially T2∗ and QSM, which exhibit considerable promise in grading and molecular subtype assessment of diffuse gliomas.
引用
- Lin D, Xu G, He H, et al. The evaluation value of multiparametric imaging technology (MULTIPLEX) for grading and molecular subtyping of diffuse glioma patients. Clin Radiol. 2026. PMID: 41797072. doi:10.1016/j.crad.2026.107265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。